Page last updated: 2024-10-29

ketanserin and Diabetic Nephropathies

ketanserin has been researched along with Diabetic Nephropathies in 1 studies

Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.

Diabetic Nephropathies: KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kasho, M1
Sakai, M1
Sasahara, T1
Anami, Y1
Matsumura, T1
Takemura, T1
Matsuda, H1
Kobori, S1
Shichiri, M1

Other Studies

1 other study available for ketanserin and Diabetic Nephropathies

ArticleYear
Serotonin enhances the production of type IV collagen by human mesangial cells.
    Kidney international, 1998, Volume: 54, Issue:4

    Topics: Cells, Cultured; Collagen; Diabetic Nephropathies; Glomerular Mesangium; Humans; Ketanserin; Kinetic

1998